The STOIC2021 COVID-19 AI challenge: applying reusable training methodologies to private data
Authors:
Luuk H. Boulogne,
Julian Lorenz,
Daniel Kienzle,
Robin Schon,
Katja Ludwig,
Rainer Lienhart,
Simon Jegou,
Guang Li,
Cong Chen,
Qi Wang,
Derik Shi,
Mayug Maniparambil,
Dominik Muller,
Silvan Mertes,
Niklas Schroter,
Fabio Hellmann,
Miriam Elia,
Ine Dirks,
Matias Nicolas Bossa,
Abel Diaz Berenguer,
Tanmoy Mukherjee,
Jef Vandemeulebroucke,
Hichem Sahli,
Nikos Deligiannis,
Panagiotis Gonidakis
, et al. (13 additional authors not shown)
Abstract:
Challenges drive the state-of-the-art of automated medical image analysis. The quantity of public training data that they provide can limit the performance of their solutions. Public access to the training methodology for these solutions remains absent. This study implements the Type Three (T3) challenge format, which allows for training solutions on private data and guarantees reusable training m…
▽ More
Challenges drive the state-of-the-art of automated medical image analysis. The quantity of public training data that they provide can limit the performance of their solutions. Public access to the training methodology for these solutions remains absent. This study implements the Type Three (T3) challenge format, which allows for training solutions on private data and guarantees reusable training methodologies. With T3, challenge organizers train a codebase provided by the participants on sequestered training data. T3 was implemented in the STOIC2021 challenge, with the goal of predicting from a computed tomography (CT) scan whether subjects had a severe COVID-19 infection, defined as intubation or death within one month. STOIC2021 consisted of a Qualification phase, where participants developed challenge solutions using 2000 publicly available CT scans, and a Final phase, where participants submitted their training methodologies with which solutions were trained on CT scans of 9724 subjects. The organizers successfully trained six of the eight Final phase submissions. The submitted codebases for training and running inference were released publicly. The winning solution obtained an area under the receiver operating characteristic curve for discerning between severe and non-severe COVID-19 of 0.815. The Final phase solutions of all finalists improved upon their Qualification phase solutions.HSUXJM-TNZF9CHSUXJM-TNZF9C
△ Less
Submitted 25 June, 2023; v1 submitted 18 June, 2023;
originally announced June 2023.
On the Composition and Limitations of Publicly Available COVID-19 X-Ray Imaging Datasets
Authors:
Beatriz Garcia Santa Cruz,
Jan Sölter,
Matias Nicolas Bossa,
Andreas Dominik Husch
Abstract:
Machine learning based methods for diagnosis and progression prediction of COVID-19 from imaging data have gained significant attention in the last months, in particular by the use of deep learning models. In this context hundreds of models where proposed with the majority of them trained on public datasets. Data scarcity, mismatch between training and target population, group imbalance, and lack…
▽ More
Machine learning based methods for diagnosis and progression prediction of COVID-19 from imaging data have gained significant attention in the last months, in particular by the use of deep learning models. In this context hundreds of models where proposed with the majority of them trained on public datasets. Data scarcity, mismatch between training and target population, group imbalance, and lack of documentation are important sources of bias, hindering the applicability of these models to real-world clinical practice. Considering that datasets are an essential part of model building and evaluation, a deeper understanding of the current landscape is needed. This paper presents an overview of the currently public available COVID-19 chest X-ray datasets. Each dataset is briefly described and potential strength, limitations and interactions between datasets are identified. In particular, some key properties of current datasets that could be potential sources of bias, impairing models trained on them are pointed out. These descriptions are useful for model building on those datasets, to choose the best dataset according the model goal, to take into account the specific limitations to avoid reporting overconfident benchmark results, and to discuss their impact on the generalisation capabilities in a specific clinical setting
△ Less
Submitted 26 August, 2020;
originally announced August 2020.
